HPV primary testing without the need for a traditional Pap smear performed with a speculum...
Focusing on continuous monitoring to identify and address clinical deterioration early...
Synapse 3D is equipped with specialised technology which identifies three optimal paths leading to a lung lesion...
Beurer India unveils cricket legend Sourav Ganguly as its new Brand Ambassador...
Industry captains and key stakeholders to brainstorm on the Value Chain Mapping of the select medical devices...
For eligible patients diagnosed with breast, ovarian, prostate and pancreatic cancer...
Beckman Coulter now an authorised distributor of MeMed key immunoassay system and MeMed BV assay...
A high-performance head-only MR scanner in comparison to conventional whole-body MR systems known so far...
CRISPR/Cas system, a popular gene editing system known for its targeted genomic cleaving capabilities, is being widely used for the development of gene edited therapies. Since 2016, CRISPR/Cas has also been extensively used for the development of molecular diagnostics and other biosensing applications. Due to targeted biosensing, CRISPR-based diagnostics can be developed as highly specific, rapid, simple, and cost-efficient tests that can be used at scale and in point-of-care (POC) settings. CRI...
Developing new cost-effective detection technologies for volatile organic compounds (VOCs)...
![[L-R]: Ms. Vivien Tan, XP Business Manager, Siemens Healthineers ASEAN; Prof. Dr. dr. Lina Choridah, Sp.Rad (K), Chairwoman Indonesian Woman Imaging Society; Hendya Perbangkara, Head of Diagnostic Imaging, Siemens Healthineers Indonesia](/uploads/articles/l_r__ms_vivien_tan_xp_business_manager_siemens_healthineers_asean-24188.jpg)
